Stanozolol 10 mg Tablets
- Pickup from New Mail
- New Mail Courier
- Pickup from the store
- Other transport services
- Cash upon receipt
- Bank transfer
- Privat 24
- WebMoney
Stanozolol 10 mg Tablets — La Pharma
- Brand: La Pharma
- Category: Oral AAS Research Compound
- Content: 100 tablets 10 mg (1,000 mg total)
- Manufactured in: Thailand
Product Overview
Stanozolol 10 mg (also known as Winstrol or Stromba forte) is a synthetic
anabolic–androgenic steroid (AAS) used in research involving androgen receptor (AR)
signaling, protein synthesis pathways, nitrogen balance, and steroid metabolism.
Its 17--alkylation provides oral bioactivity while creating a well-documented
hepatotoxicity profile relevant for toxicology studies.
Stanozolol is listed under the S1 “Anabolic Agents” category of anti-doping
regulations and is prohibited in all sports contexts. Research samples must therefore
be handled with strict laboratory controls and contamination-avoidance protocols.
Key Research Highlights
Strong AR agonism:
Promotes transcription of anabolic genes involved in protein synthesis and connective-tissue processes.
Oral bioavailability via 17--methylation:
Allows consistent oral dosing in in-vitro and in-vivo research while elevating hepatic stress markers.
Hepatotoxicity modeling:
Stanozolol is frequently used in liver-toxicity assays due to cholestasis, peliosis hepatis,
and enzyme-alteration signals reported in literature.
Toxicology & metabolism research:
Shows microsomal enzyme changes, androgenic behavior, and steroid-metabolism variations relevant for mechanistic studies.
Suggested Laboratory Applications
- Androgen receptor (AR) binding and transcriptional regulation assays
- Protein synthesis & nitrogen balance pathway studies
- Hepatic metabolism and toxicology analysis of 17--alkylated steroids
- Skeletal-muscle anabolic modeling
- Comparative AAS potency and metabolic profiling
Technical Specifications
| Parameter | Value |
|---|---|
| Field | Value |
| Chemical Name | Stanozolol |
| IUPAC / Systematic Name | 17-Hydroxy-17-methyl-5-androstano[3,2-c]pyrazole |
| Synonyms | Winstrol; STZ; Stromba |
| Molecular Formula | C21H32N2O |
| Molecular Weight | ~328.49 g/mol |
| CAS Number | 10418-03-8 |
| PubChem CID | 25249 |
| Total Active Content | 1,000 mg per bottle (100 10 mg tablets) |
| Handling Notes | Store sealed, cool, dry, protected from light; PPE recommended in controlled settings |
| Anti-Doping Status | WADA S1 Anabolic Agents — prohibited at all times |
PubChem-Supported Research Insights
- Strong AR activation with measurable transcriptional effects
- Microsomal enzyme alterations linked to hepatic stress
- Useful in anabolic and connective-tissue gene expression models
- Extensively referenced in anti-doping detection and metabolism studies
- Long-term metabolite profiles assist testing-method development
Documented Research Side Effects
- Cholestatic liver injury, peliosis hepatis, elevated transaminases
- Dyslipidemia (HDL / LDL)
- Androgenic markers: acne, hair changes, voice deepening in female models
- Nitrogen/water-balance shifts
- Endocrine suppression and HPTA impact
Handling & Compliance
For Research Use Only — not for human or veterinary application.
Stanozolol is prohibited under WADA S1; avoid any contamination in sport-testing environments.
Store sealed, protected from light; dispose of according to institutional chemical-safety rules.
No dosing or therapeutic claims are made; supplied solely for qualified laboratory professionals.
-
Package:100 tablets 10 mg (1.000 mg total)
-
CAS Number:10418-03-8
-
Molecular formula:C21H32N2O
-
Country of manufacture:Thailand